Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fructosamine-3-Kinase as a Potential Treatment Option for Age-Related Macular Degeneration.
De Bruyne S, Van den Broecke C, Vrielinck H, Khelifi S, De Wever O, Bracke K, Huizing M, Boston N, Himpe J, Speeckaert M, Vral A, Van Dorpe J, Van Aken E, Delanghe JR. De Bruyne S, et al. Among authors: van den broecke c. J Clin Med. 2020 Sep 4;9(9):2869. doi: 10.3390/jcm9092869. J Clin Med. 2020. PMID: 32899850 Free PMC article.
A Potential Role for Fructosamine-3-Kinase in Cataract Treatment.
De Bruyne S, van Schie L, Himpe J, De Somer F, Everaert I, Derave W, Van den Broecke C, Huizing M, Bostan N, Speeckaert M, Callewaert N, Van Aken E, Delanghe JR. De Bruyne S, et al. Among authors: van den broecke c. Int J Mol Sci. 2021 Apr 7;22(8):3841. doi: 10.3390/ijms22083841. Int J Mol Sci. 2021. PMID: 33917258 Free PMC article.
Shallow whole-genome sequencing: a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue-a glioma-driven study.
Van der Eecken K, Van der Linden M, Raman L, Creytens D, Dedeurwaerdere F, De Winne K, Ferdinande L, Lammens M, Menten B, Rottiers I, Van Gaever B, Van den Broecke C, Van de Vijver K, Van Roy N, Verbeke S, Van Dorpe J. Van der Eecken K, et al. Among authors: van den broecke c. Virchows Arch. 2022 Mar;480(3):677-686. doi: 10.1007/s00428-022-03268-w. Epub 2022 Jan 16. Virchows Arch. 2022. PMID: 35034191
Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study.
Pinson H, Hallaert G, Van der Meulen J, Dedeurwaerdere F, Vanhauwaert D, Van den Broecke C, Van Dorpe J, Van Roost D, Kalala JP, Boterberg T. Pinson H, et al. Among authors: van der meulen j, van roost d, van dorpe j, van den broecke c. J Neurooncol. 2020 Jan;146(1):55-62. doi: 10.1007/s11060-019-03334-5. Epub 2019 Nov 7. J Neurooncol. 2020. PMID: 31701343
75 results